The Deal

ROCKVILLE, MARYLAND — Behavioral Framework today announced that Autism ETC, a highly regarded provider of center-based applied behavior analysis therapy and autism diagnostic services, is joining its platform. Backed by Renovus Capital Partners, a lower middle-market private equity firm headquartered in the Philadelphia area, Behavioral Framework is partnering with Autism ETC to further a shared commitment to expanding access to high-quality, compassionate care for children with autism and their families.

Founded in 2007, Autism ETC operates five clinics across Tennessee and Arizona and has built a strong reputation for clinical excellence, experienced clinicians, and a family-centered approach. The company’s services include ABA therapy, autism diagnostic services, and school-like day programs. Rhonda Manous, executive director of Autism ETC, noted that many employees have been with the organization for years—something almost unheard of in the ABA industry, where turnover rates are a persistent challenge. The Autism ETC leadership team and clinical staff will remain in place following the acquisition.

Behavioral Framework was founded in 2017 in Rockville, Maryland, by Angela West. The company provides ABA therapy and autism diagnostic services through its Pathways division. Kyle West serves as CEO, and Angela West serves as Chief Clinical Officer. Prior to the Autism ETC acquisition, Behavioral Framework operated across Maryland, Virginia, North Carolina, and Washington, D.C. The company appeared on the Inc. 5,000 list of fastest-growing companies in 2025, ranking number 2,166 with 198 percent three-year revenue growth. The Autism ETC deal is the company’s second add-on acquisition; Behavioral Framework acquired Behavior Consultation and Psychological Services in July 2024.

Autism ETC’s employee retention—with many staff members in place for years—is something almost unheard of in the ABA industry. That retention signals clinical stability, which is exactly what PE-backed acquirers are prioritizing in 2026.

The Renovus Thesis

Renovus Capital Partners made its growth investment in Behavioral Framework in January 2024, announcing the partnership with a clear thesis: there is a critical need nationwide for autism diagnostics and ABA therapy, and Behavioral Framework’s clinical model—grounded in compassion, measurable results, and family-focused care—could be scaled to reach new communities. Jesse Serventi, Founding Partner at Renovus, characterized the West leadership team as having a strong position in the growing ABA space.

Renovus manages over $2 billion in assets across its sector-focused funds, specializing in the Knowledge and Talent industries. The firm’s current portfolio includes more than 30 U.S.-based businesses in education, workforce development, technology, healthcare, and professional services. The ABA investment fits within Renovus’s broader thesis of backing service businesses in fragmented markets where operational improvements, talent recruitment, and add-on acquisitions can drive scaled growth.

The Autism ETC acquisition demonstrates the classic PE add-on playbook: acquire a well-run practice with strong clinical culture and employee retention, preserve its leadership, and integrate it into the platform’s operational infrastructure for administrative efficiency and geographic expansion. Cain Brothers, a division of KeyBanc Capital Markets, served as the exclusive financial advisor to Behavioral Framework on the initial Renovus investment. Pat Heath, Vice President at Renovus, described Autism ETC as an outstanding organization with a strong reputation in its communities.

Strategic Fit: Geographic Expansion

The Autism ETC acquisition is significant primarily for its geographic implications. Before the deal, Behavioral Framework’s footprint was concentrated in the Mid-Atlantic—Maryland, Virginia, North Carolina, and the District of Columbia. The acquisition of five clinics in Tennessee and Arizona immediately extends the platform into two new regions: the Southeast and the Southwest.

Tennessee is one of the fastest-growing ABA markets in the country. Nashville has become a hub for behavioral health company headquarters—JoyBridge Kids, which recently acquired Pediatric Advanced Therapy, is based in Mount Juliet, Tennessee. Arizona is similarly attractive: ACES acquired Ally Pediatric Therapy in Phoenix in January 2026, expanding its Arizona footprint to 92 locations. Behavioral Framework’s entry into both states positions it to compete for market share in regions where demand for ABA services is growing and where other PE-backed platforms are actively investing.

The strategic logic extends beyond geography. Autism ETC’s diagnostic services complement Behavioral Framework’s existing Pathways diagnostic division, creating a multi-state diagnostic platform that can identify ASD earlier and funnel diagnosed children into ABA treatment. This diagnostic-to-treatment pipeline is a competitive advantage that accelerates patient acquisition and improves clinical continuity.

What This Signals About 2026 M&A

The Behavioral Framework–Autism ETC transaction is the first major ABA expansion deal announced in January 2026—and it signals that PE-backed platforms are entering the year with acquisition appetite. The deal closed just days into the new year, suggesting that diligence and negotiations were substantially complete in Q4 2025, when the ABA M&A market was showing signs of recovering from the 2023–2024 slowdown.

Several characteristics of this deal reflect broader trends. First, the acquirer is a lower middle-market platform—not a megacap PE roll-up. Renovus’s $2 billion in AUM places it in a different category than firms like General Atlantic ($85 billion AUM) or Blackstone. This suggests that ABA M&A activity is broadening beyond the largest sponsors to include mid-market PE firms targeting smaller, high-quality practices.

Second, the target is a founder-led, clinically driven organization with strong employee retention and community reputation—exactly the profile that commands premium multiples in the current market. Buyers are being more selective in 2026, prioritizing clinical quality, staff stability, and clean compliance records over raw scale. Autism ETC’s 18-year operating history and loyal workforce make it a textbook acquisition target in this environment.

Third, the deal preserves existing leadership. The retention of Rhonda Manous and the Autism ETC clinical team is both a cultural signal and an operational necessity. In ABA, the clinical relationships between BCBAs, behavior technicians, and families are the core of the business. Disrupting those relationships through leadership turnover is the fastest way to destroy the value of an acquisition. Smart acquirers—and Behavioral Framework appears to be one—prioritize continuity.

For practice owners considering an eventual exit, the Behavioral Framework–Autism ETC deal provides a useful benchmark. It demonstrates that mid-market PE firms are actively seeking ABA targets, that clinical quality and staff retention are the differentiators that drive deal activity, and that geographic expansion into underserved markets creates strategic value for acquirers. The ABA M&A market in 2026 is more selective than the frenzy of 2019–2022—but for well-run practices with strong fundamentals, the buyer demand is real.

AT A GLANCE

SOURCES & REFERENCES